{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:55:48Z","timestamp":1793019348099,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LY21H160053"],"award-info":[{"award-number":["LY21H160053"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Key research fund of Hangzhou Medical College","award":["KYZD2023011"],"award-info":[{"award-number":["KYZD2023011"]}],"id":[{"id":"https:\/\/ror.org\/05gpas306","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05955-8","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:54:43Z","timestamp":1764078883000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Histone lactylation drives METTL3 upregulation-mediated RNA m6A modification of CCT2 to hinder CD8+ T cell survival in gastric cancer"],"prefix":"10.1007","volume":"83","author":[{"given":"Zhenyuan","family":"Qian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xufan","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaiyuan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1583-4240","authenticated-orcid":false,"given":"Jianzhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"issue":"3","key":"5955_CR1","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5662\/wjm.v13.i3.79","volume":"13","author":"W Leowattana","year":"2023","unstructured":"Leowattana W, Leowattana P, Leowattana T (2023) Immunotherapy for advanced gastric cancer. World J Methodol 13(3):79\u201397","journal-title":"World J Methodol"},{"key":"5955_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1016817","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li C, Lu Y, Liu C, Yang W (2022) Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer. Front Immunol 13:1016817","journal-title":"Front Immunol"},{"key":"5955_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.964442","volume":"13","author":"Q Tang","year":"2022","unstructured":"Tang Q, Chen Y, Li X, Long S, Shi Y, Yu Y, Wu W, Han L, Wang S (2022) The role of PD-1\/PD-L1 and application of immune-checkpoint inhibitors in human cancers. Front Immunol 13:964442","journal-title":"Front Immunol"},{"issue":"22","key":"5955_CR4","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.2217\/fon-2021-0176","volume":"17","author":"J Tabernero","year":"2021","unstructured":"Tabernero J, Bang YJ, Van Cutsem E, Fuchs CS, Janjigian YY, Bhagia P, Li K, Adelberg D, Qin SK (2021) KEYNOTE-859: a phase III study of pembrolizumab plus chemotherapy in gastric\/gastroesophageal junction adenocarcinoma. Future Oncol 17(22):2847\u20132855","journal-title":"Future Oncol"},{"key":"5955_CR5","doi-asserted-by":"crossref","unstructured":"Marabelle A, Le DT, Ascierto PA, Di Giacomo AM, De Jesus-Acosta A, Delord JP, Geva R, Gottfried M, Penel N, Hansen AR, Piha-Paul SA, Doi T, Gao B, Chung HC, Lopez-Martin J, Bang YJ, Frommer RS, Shah M, Ghori R, Joe AK, Pruitt SK, Diaz LA\u00a0Jr (2020) Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability\/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. J Clin Oncol 38 (1):1\u201310","DOI":"10.1200\/JCO.19.02105"},{"issue":"12","key":"5955_CR6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1001\/jama.2022.16464","volume":"328","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Han L, Wu L, Chen J, Sun H, Wen G, Ji Y, Dvorkin M, Shi J, Pan Z, Shi J, Wang X, Bai Y, Melkadze T, Pan Y, Min X, Viguro M, Li X, Zhao Y, Yang J, Makharadze T, Arkania E, Kang W, Wang Q, Zhu J, Group A-S (2022) Effect of first-line Serplulimab vs placebo added to chemotherapy on survival in patients with extensive-stage small cell lung cancer: the ASTRUM-005 randomized clinical trial. JAMA 328(12):1223\u20131232","journal-title":"JAMA"},{"issue":"9","key":"5955_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1080\/14740338.2020.1805428","volume":"19","author":"S Mishima","year":"2020","unstructured":"Mishima S, Kawazoe A, Shitara K (2020) Safety of pembrolizumab in recurrent or advanced gastric cancer expressing PD-L1 refractory to platinum and fluoropyrimidine. Expert Opin Drug Saf 19(9):1063\u20131068","journal-title":"Expert Opin Drug Saf"},{"key":"5955_CR8","volume":"23","author":"L Chen","year":"2022","unstructured":"Chen L, Huang L, Gu Y, Cang W, Sun P, Xiang Y (2022) Lactate-lactylation hands between metabolic reprogramming and immunosuppression. Int J Mol Sci 23:19","journal-title":"Int J Mol Sci"},{"key":"5955_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1149989","volume":"14","author":"H Yang","year":"2023","unstructured":"Yang H, Zou X, Yang S, Zhang A, Li N, Ma Z (2023) Identification of lactylation related model to predict prognostic, tumor infiltrating immunocytes and response of immunotherapy in gastric cancer. Front Immunol 14:1149989","journal-title":"Front Immunol"},{"key":"5955_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1229397","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang R, Hei H (2023) Advances in post-translational modifications of proteins and cancer immunotherapy. Front Immunol 14:1229397","journal-title":"Front Immunol"},{"issue":"1","key":"5955_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02308-z","volume":"22","author":"J Yu","year":"2021","unstructured":"Yu J, Chai P, Xie M, Ge S, Ruan J, Fan X, Jia R (2021) Histone lactylation drives oncogenesis by facilitating m(6)A reader protein YTHDF2 expression in ocular melanoma. Genome Biol 22(1):85","journal-title":"Genome Biol"},{"issue":"1","key":"5955_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01605-2","volume":"8","author":"ZW Huang","year":"2023","unstructured":"Huang ZW, Zhang XN, Zhang L, Liu LL, Zhang JW, Sun YX, Xu JQ, Liu Q, Long ZJ (2023) STAT5 promotes PD-L1 expression by facilitating histone lactylation to drive immunosuppression in acute myeloid leukemia. Signal Transduct Target Ther 8(1):391","journal-title":"Signal Transduct Target Ther"},{"key":"5955_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108613","volume":"112","author":"T Sun","year":"2019","unstructured":"Sun T, Wu R, Ming L (2019) The role of m6A RNA methylation in cancer. Biomed Pharmacother 112:108613","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5955_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C, Huang W, Li Y, Weng H (2020) Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol 13(1):117","journal-title":"J Hematol Oncol"},{"issue":"17","key":"5955_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202204784","volume":"10","author":"Y Feng","year":"2023","unstructured":"Feng Y, Yuan P, Guo H, Gu L, Yang Z, Wang J, Zhu W, Zhang Q, Cao J, Wang L, Jiao Y (2023) METTL3 mediates epithelial-mesenchymal transition by modulating FOXO1 mRNA N(6) -methyladenosine-dependent YTHDF2 binding: a novel mechanism of radiation-induced lung injury. Adv Sci 10(17):e2204784","journal-title":"Adv Sci"},{"issue":"3","key":"5955_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2023.130542","volume":"1868","author":"S Zhou","year":"2024","unstructured":"Zhou S, Sheng L, Zhang L, Zhang J, Wang L (2024) METTL3\/IGF2BP3-regulated m6A modification of HYOU1 confers doxorubicin resistance in breast cancer. Biochimica et Biophysica Acta (BBA) 1868(3):130542","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"9","key":"5955_CR17","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.1007\/s12033-023-00877-x","volume":"66","author":"R Li","year":"2023","unstructured":"Li R, Li Y, Wang Z, Suo R, Ma R, Zhang J (2023) MiR-181-5p\/KLHL5 promoted proliferation and migration of gastric cancer through activating METTL3-mediated m6a process. Mol Biotechnol 66(9):2415\u20132425. https:\/\/doi.org\/10.1007\/s12033-023-00877-x","journal-title":"Mol Biotechnol"},{"issue":"3","key":"5955_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41418-021-00879-9","volume":"29","author":"HT Liu","year":"2022","unstructured":"Liu HT, Zou YX, Zhu WJ, Sen L, Zhang GH, Ma RR, Guo XY, Gao P (2022) LncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus. Cell Death Differ 29(3):627\u2013641","journal-title":"Cell Death Differ"},{"issue":"7779","key":"5955_CR19","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, Liu W, Kim S, Lee S, Perez-Neut M, Ding J, Czyz D, Hu R, Ye Z, He M, Zheng YG, Shuman HA, Dai L, Ren B, Roeder RG, Becker L, Zhao Y (2019) Metabolic regulation of gene expression by histone lactylation. Nature 574(7779):575\u2013580","journal-title":"Nature"},{"issue":"9","key":"5955_CR20","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1016\/j.molcel.2022.02.033","volume":"82","author":"J Xiong","year":"2022","unstructured":"Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, Wang H, Song Y, Du Y, Cui B, Xue M, Zheng W, Kong X, Jiang K, Ding K, Lai L, Wang Q (2022) Lactylation-driven METTL3-mediated RNA m(6)A modification promotes immunosuppression of tumor-infiltrating myeloid cells. Mol Cell 82(9):1660\u20131677 e10","journal-title":"Mol Cell"},{"issue":"5","key":"5955_CR21","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1080\/1120009X.2022.2143614","volume":"35","author":"W Xu","year":"2023","unstructured":"Xu W, Liu S, Zhang G, Liu J, Cao G (2023) Knockdown of METTL5 inhibits the Myc pathway to downregulate PD-L1 expression and inhibits immune escape of hepatocellular carcinoma cells. J Chemother 35(5):455\u2013464","journal-title":"J Chemother"},{"issue":"7","key":"5955_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06944-8","volume":"15","author":"X Chen","year":"2024","unstructured":"Chen X, Ma C, Li Y, Liang Y, Chen T, Han D, Luo D, Zhang N, Zhao W, Wang L, Chen B, Guo H, Yang Q (2024) Trim21-mediated CCT2 ubiquitination suppresses malignant progression and promotes CD4(+)T cell activation in breast cancer. Cell Death Dis 15(7):542","journal-title":"Cell Death Dis"},{"key":"5955_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1253064","volume":"14","author":"J Su","year":"2023","unstructured":"Su J, Zheng Z, Bian C, Chang S, Bao J, Yu H, Xin Y, Jiang X (2023) Functions and mechanisms of lactylation in carcinogenesis and immunosuppression. Front Immunol 14:1253064","journal-title":"Front Immunol"},{"issue":"1","key":"5955_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-023-03162-8","volume":"23","author":"H Yang","year":"2023","unstructured":"Yang H, Yang S, He J, Li W, Zhang A, Li N, Zhou G, Sun B (2023) Glucose transporter 3 (GLUT3) promotes lactylation modifications by regulating lactate dehydrogenase A (LDHA) in gastric cancer. Cancer Cell Int 23(1):303","journal-title":"Cancer Cell Int"},{"issue":"12","key":"5955_CR25","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1002\/jbmr.4142","volume":"35","author":"AM Hollenberg","year":"2020","unstructured":"Hollenberg AM, Smith CO, Shum LC, Awad H, Eliseev RA (2020) Lactate dehydrogenase inhibition with oxamate exerts bone anabolic effect. J Bone Miner Res 35(12):2432\u20132443","journal-title":"J Bone Miner Res"},{"key":"5955_CR26","doi-asserted-by":"crossref","unstructured":"Zakaria S, Elsebaey S, Allam S, Abdo W, El-Sisi A (2023) Siah2 inhibitor and the metabolic antagonist oxamate retard colon cancer progression and downregulate PD1 expression. Recent Pat Anticancer Drug Discov","DOI":"10.2174\/1574892818666230116142606"},{"issue":"1","key":"5955_CR27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.canlet.2014.11.046","volume":"358","author":"Z Zhao","year":"2015","unstructured":"Zhao Z, Han F, Yang S, Wu J, Zhan W (2015) Oxamate-mediated inhibition of lactate dehydrogenase induces protective autophagy in gastric cancer cells: involvement of the Akt-mTOR signaling pathway. Cancer Lett 358(1):17\u201326","journal-title":"Cancer Lett"},{"issue":"1","key":"5955_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02815-w","volume":"42","author":"T Sun","year":"2023","unstructured":"Sun T, Liu B, Li Y, Wu J, Cao Y, Yang S, Tan H, Cai L, Zhang S, Qi X, Yu D, Yang W (2023) Oxamate enhances the efficacy of CAR-T therapy against glioblastoma via suppressing ectonucleotidases and CCR8 lactylation. J Exp Clin Cancer Res 42(1):253","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5955_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s43556-025-00275-6","volume":"6","author":"X Peng","year":"2025","unstructured":"Peng X, Du J (2025) Histone and non-histone lactylation: molecular mechanisms, biological functions, diseases, and therapeutic targets. Mol Biomed 6(1):38","journal-title":"Mol Biomed"},{"issue":"1","key":"5955_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32521-8","volume":"13","author":"Q Feng","year":"2022","unstructured":"Feng Q, Liu Z, Yu X, Huang T, Chen J, Wang J, Wilhelm J, Li S, Song J, Li W, Sun Z, Sumer BD, Li B, Fu YX, Gao J (2022) Lactate increases stemness of CD8\u2009+\u2009T cells to augment anti-tumor immunity. Nat Commun 13(1):4981","journal-title":"Nat Commun"},{"issue":"12","key":"5955_CR31","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.it.2022.10.005","volume":"43","author":"P Apostolova","year":"2022","unstructured":"Apostolova P, Pearce EL (2022) Lactic acid and lactate: revisiting the physiological roles in the tumor microenvironment. Trends Immunol 43(12):969\u2013977","journal-title":"Trends Immunol"},{"issue":"1","key":"5955_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-023-02638-9","volume":"42","author":"Y Sun","year":"2023","unstructured":"Sun Y, Shen W, Hu S, Lyu Q, Wang Q, Wei T, Zhu W, Zhang J (2023) Mettl3 promotes chemoresistance in small cell lung cancer by inducing mitophagy. J Exp Clin Cancer Res 42(1):65","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"5955_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-03071-y","volume":"11","author":"Q Wang","year":"2020","unstructured":"Wang Q, Guo X, Li L, Gao Z, Su X, Ji M, Liu J (2020) N(6)-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1\/HK2 modification. Cell Death Dis 11(10):911","journal-title":"Cell Death Dis"},{"issue":"16","key":"5955_CR34","doi-asserted-by":"publisher","first-page":"7640","DOI":"10.7150\/thno.61178","volume":"11","author":"Y Chen","year":"2021","unstructured":"Chen Y, Pan C, Wang X, Xu D, Ma Y, Hu J, Chen P, Xiang Z, Rao Q, Han X (2021) Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells. Theranostics 11(16):7640\u20137657","journal-title":"Theranostics"},{"issue":"1","key":"5955_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34209-5","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, He X, Lu X, Gong Z, Li Q, Zhang L, Yang R, Wu C, Huang J, Ding J, He Y, Liu W, Chen C, Cao B, Zhou D, Shi Y, Chen J, Wang C, Zhang S, Zhang J, Ye J, You H (2022) METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions. Nat Commun 13(1):6350","journal-title":"Nat Commun"},{"issue":"7","key":"5955_CR36","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J, Jiang Z, Zhang Y, Xu G, Zhang J, Zhou J, Sun B, Zou X, Wang S (2020) METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut 69(7):1193\u20131205","journal-title":"Gut"},{"issue":"9","key":"5955_CR37","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.7150\/ijbs.70674","volume":"18","author":"R Yu","year":"2022","unstructured":"Yu R, Wei Y, He C, Zhou P, Yang H, Deng C, Liu R, Wu P, Gao Q, Cao C (2022) Integrative analyses of m6A regulators identify that METTL3 is associated with HPV status and immunosuppressive microenvironment in HPV-related cancers. Int J Biol Sci 18(9):3874\u20133887","journal-title":"Int J Biol Sci"},{"key":"5955_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101423","volume":"20","author":"X Ma","year":"2022","unstructured":"Ma X, Qiu S, Tang X, Song Q, Wang P, Wang J, Xia Q, Wang Z, Zhao Q, Lu M (2022) TSPAN31 regulates the proliferation, migration, and apoptosis of gastric cancer cells through the METTL1\/CCT2 pathway. Transl Oncol 20:101423","journal-title":"Transl Oncol"},{"issue":"2","key":"5955_CR39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/biom13020243","volume":"13","author":"W Meng","year":"2023","unstructured":"Meng W, Xiao H, Mei P, Chen J, Wang Y, Zhao R, Liao Y (2023) Critical roles of METTL3 in translation regulation of cancer. Biomolecules 13(2):243. https:\/\/doi.org\/10.3390\/biom13020243","journal-title":"Biomolecules"},{"issue":"16","key":"5955_CR40","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1038\/s41388-021-01753-1","volume":"40","author":"FC Huo","year":"2021","unstructured":"Huo FC, Zhu ZM, Zhu WT, Du QY, Liang J, Mou J (2021) METTL3-mediated m(6)A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2. Oncogene 40(16):2968\u20132981","journal-title":"Oncogene"},{"issue":"1","key":"5955_CR41","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41388-019-0972-6","volume":"39","author":"SH Park","year":"2020","unstructured":"Park SH, Jeong S, Kim BR, Jeong YA, Kim JL, Na YJ, Jo MJ, Yun HK, Kim DY, Kim BG, Lee DH, Oh SC (2020) Activating CCT2 triggers Gli-1 activation during hypoxic condition in colorectal cancer. Oncogene 39(1):136\u2013150","journal-title":"Oncogene"},{"key":"5955_CR42","doi-asserted-by":"crossref","unstructured":"Xu M, Gong J, Signature P (2022) Immune Features, and Therapeutic Responses of a Novel Ubiquitination-Related Gene Signature in Lung Adenocarcinoma. J Oncol 2022:2524649","DOI":"10.1155\/2022\/2524649"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05955-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05955-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05955-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T12:02:13Z","timestamp":1767096133000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05955-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5955"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05955-8","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Zhejiang Provincial People\u2019s Hospital, approval number: 2024 (177) and the Animal Ethics Committee of Zhejiang Provincial People\u2019s Hospital, approval number: 20240724114052566087.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicting interests"}}],"article-number":"17"}}